CYTK
Price
$48.53
Change
-$0.42 (-0.86%)
Updated
Dec 24, 02:00 PM (EDT)
57 days until earnings call
GHRS
Price
$7.09
Change
+$0.09 (+1.29%)
Updated
Dec 24, 02:00 PM (EDT)
65 days until earnings call
Ad is loading...

CYTK vs GHRS

Header iconCYTK vs GHRS Comparison
Open Charts CYTK vs GHRSBanner chart's image
Cytokinetics
Price$48.53
Change-$0.42 (-0.86%)
Volume$55.16K
CapitalizationN/A
GH Research
Price$7.09
Change+$0.09 (+1.29%)
Volume$637
CapitalizationN/A
CYTK vs GHRS Comparison Chart
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. GHRS commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Buy and GHRS is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (CYTK: $48.53 vs. GHRS: $7.09)
Brand notoriety: CYTK and GHRS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 26% vs. GHRS: 69%
Market capitalization -- CYTK: $5.73B vs. GHRS: $368.88M
CYTK [@Biotechnology] is valued at $5.73B. GHRS’s [@Biotechnology] market capitalization is $368.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileGHRS’s FA Score has 1 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • GHRS’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than GHRS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 4 TA indicator(s) are bullish while GHRS’s TA Score has 3 bullish TA indicator(s).

  • CYTK’s TA Score: 4 bullish, 6 bearish.
  • GHRS’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, CYTK is a better buy in the short-term than GHRS.

Price Growth

CYTK (@Biotechnology) experienced а +1.57% price change this week, while GHRS (@Biotechnology) price change was -16.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.32%.

Reported Earning Dates

CYTK is expected to report earnings on Feb 20, 2025.

GHRS is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (-0.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($5.73B) has a higher market cap than GHRS($369M). GHRS YTD gains are higher at: 20.690 vs. CYTK (-41.873). GHRS has higher annual earnings (EBITDA): -41.07M vs. CYTK (-481.94M). CYTK has more cash in the bank: 1.01B vs. GHRS (150M). GHRS has less debt than CYTK: GHRS (733K) vs CYTK (790M). CYTK has higher revenues than GHRS: CYTK (3.22M) vs GHRS (0).
CYTKGHRSCYTK / GHRS
Capitalization5.73B369M1,552%
EBITDA-481.94M-41.07M1,174%
Gain YTD-41.87320.690-202%
P/E RatioN/AN/A-
Revenue3.22M0-
Total Cash1.01B150M675%
Total Debt790M733K107,776%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
47
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKGHRS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 8 days ago
90%
Declines
ODDS (%)
Bearish Trend 7 days ago
77%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
INRSX15.550.10
+0.65%
Delaware Ivy Natural Resources R6
EILAX12.180.06
+0.50%
Eaton Vance International Small-Cap A
TESRX24.440.07
+0.29%
Franklin Mutual Shares R
ERSTX25.440.05
+0.20%
Eaton Vance Large-Cap Value R
VGWIX21.540.03
+0.14%
Vanguard Global Wellesley Income Inv

GHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GHRS has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GHRS jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GHRS
1D Price
Change %
GHRS100%
+2.19%
MDGL - GHRS
43%
Loosely correlated
+0.79%
IBRX - GHRS
31%
Poorly correlated
+1.91%
ORMP - GHRS
31%
Poorly correlated
+0.42%
CYTK - GHRS
30%
Poorly correlated
+0.16%
ALNY - GHRS
29%
Poorly correlated
-1.30%
More